Uterine Cancer

<i>BRCA1</i> Mutations May Raise Risk of Serous and Serous-Like Uterine Cancer

BRCA1 Mutations May Raise Risk of Serous and Serous-Like Uterine Cancer

Although overall risk for uterine cancer after risk-reducing salpingo-oophorectomy is not increased, the risk of serous/serous-like endometrial carcinoma is higher for BRCA1+ women.

Immune Therapy Drug Shows Early Promise in Subtype of Endometrial Uterine Cancer

By

In a small group of women with mismatch repair (MMR) deficiency endometrial uterine cancer, survival was increased by pembrolizumab.

Minimally Invasive Hysterectomy Linked to Favorable Survival in Uterine Cancer

Minimally Invasive Hysterectomy Linked to Favorable Survival in Uterine Cancer

Use of minimally invasive hysterectomy is linked to favorable morbidity profile and does not compromise long-term survival for patients.

Familial Risk and Heritability of Cancer Is Higher Among Twins

By

Twins carry a significant excess familial risk for cancer overall and for specific types of cancer, including prostate, melanoma, breast, ovary, and uterus, according to a long-term follow-up study of twins in Nordic countries.

Incidence of Undetected Cancer in Patients Undergoing Gynecologic Surgery for a Benign Condition Higher Than Estimated

By

Researchers in Massachusetts sought to determine how frequently cancer is diagnosed in women after undergoing gynecologic surgery for a problem believed to be benign.

Hispanic women less likely to survive endometrial uterine cancer

By

Hispanic women in the United States were significantly less likely to survive endometrial uterine cancer than non-Hispanic white women.

Presence of uterine cancers examined among women at the time of hysterectomy using morcellation

By

Among women undergoing a minimally invasive hysterectomy using electric power morcellation, uterine cancers were present in 27 per 10,000 women at the time of the procedure, according to a new study.

Women undergoing morcellation have in 27 in 10k uterine cancer prevalence

Women undergoing morcellation have in 27 in 10k uterine cancer prevalence

For women undergoing hysterectomy by morcellation, the prevalence of uterine cancers is 27 per 10,000, with increased prevalence with advanced age, according to a research letter published online.

FDA: Fibroid removal may risk spreading cancer to other bodily areas

FDA: Fibroid removal may risk spreading cancer to other bodily areas

The FDA says there is little to no evidence that a popular technique for removing fibroids can be performed without the risk of spreading undetected cancers to other parts of the body.

SGO: Bariatric surgery may lower uterine cancer risk

SGO: Bariatric surgery may lower uterine cancer risk

A history of bariatric surgery is associated with a reduction in the risk of uterine malignancy, whereas BRCA1 carriers have an increased risk of high-risk uterine cancer, according to two studies.

Longer wait for uterine cancer surgery reduces survival

Longer wait for uterine cancer surgery reduces survival

The best outcome for wait times falls between 2.1 and 12.0 weeks time.

Metastatic Cancer (Fact Sheet)

This fact sheet reviews common sites of cancer metastasis, methods of spread, treatment, and additional details.

Fertility drugs not linked to uterine cancer recurrence

Fertility drugs not linked to uterine cancer recurrence

Five-year disease-free survival similar for women who did or did not receive fertility drugs.

Higher risk of uterine cancer recurrence when radiation therapy after hysterectomy is delayed

The risk of uterine cancer recurrence may be increased by waiting too long after a hysterectomy to begin radiation therapy. For patients with uterine cancer who are not receiving chemotherapy, tumors were found to be more likely to return if radiation therapy was delayed 9 weeks or longer following surgery.

Gene variant linked to uterine fibroid risk

Gene variant linked to uterine fibroid risk

SNP which spans FASN upregulated in neoplasms and implicated in tumor cell survival.

Lung, pancreas only major cancers projected to have higher mortality in Europe in 2012

With the exception of lung cancer in women and pancreatic cancer, mortality from major cancers is expected to decline in the European Union in 2012.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs